The effect of ciprofibrate on flow-mediated dilation and inflammatory markers in patients with combined hyperlipidemia

Endothelium: Journal of Endothelial Cell Research

Volumn 12, Issue 4, 2005, Pages 179-183

  Kovács, Imre ^a   Toldy, Erzsébet ^a   Ábel, Tatjana ^b   Tarján, Jenö ^a   Császár, Albert ^b  

^a Markusovszky Teaching Hospital   (Hungary)

^b NATIONAL MEDICAL CENTER   (Hungary)

Author keywords

Ciprofibrate; Combined hyperlipidemia; Endothelial function; Flow mediated dilation; Inflammatory markers

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; CIPROFIBRATE; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYSIS OF VARIANCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ANTILIPEMIC AGENTS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CLOFIBRIC ACID; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; IMMUNOLOGIC FACTORS; MALE; VASODILATION;

EID: 27744452548     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320500227259     Document Type: Article

References (29)

1. Abe Y., El-Masri B., Kimball K.T., Pownall H., Reilly C.F., Osmundsen K., Smith C.W., and Ballantyne C.M. (1998) Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arteriosclerosis Thrombosis and Vascular Biology, 18, 723-731.
2. Capell W.H., DeSouza C.A., Poirier P., Bell M.L., Stauffer B.L., Weil K.M., Hernandez T.L., and Eckel R.H. (2003) Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia. Arteriosclerosis Thrombosis and Vascular Biology, 23, 307-333.
3. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., and Deanfield J.E. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340, 1111-1115.
4. Glass C.K., and Witztum J.L. (2001) Atherosclerosis: The road ahead. Cell, 104, 503-516.
5. Goodfellow J., Bellamy M.F., Ramsey M.W., Jones C.J., and Lewis M.J. (2000) Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. Journal of American College of Cardiology, 35, 265-270.
6. Hackman A., Abe Y., Insull W. Jr., Pownall H., Smith L., Dunn K., Gotto A.M. Jr., and Ballantyne C.M. (1996) Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation, 93, 1334-1338.
7. Haller H., Schaper D., Ziegler W., Philipp S., Kuhlmann M., Distler A., and Luft F.C. (1995) Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension, 25, 511-551.
8. Hardardottir I., Grunfeld C., and Feingold K.R. (1994) Effects of endotoxin and cytokines on tipid metabolism. Current Opinion in Lipidology, 5, 207-215.
9. Kovacs I., Tarjan J., and Csaszar A. (2001) [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia] [Article in Hungarian] Orvosi Hetilap, 142, 775-779.
10. Kume N., Cybulsky M.I., and Gimbrone M.A. Jr. (1992) Lysophosphatidyl-choline, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. Journal of Clinical Investigation, 90, 1138-1144.
11. Neunteufl T., Heher S., Katzenschlager R., Wolfl G., Kostner K., Maurer G., and Weidinger F. (2000) Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. The American Journal of Cardiology, 86, 207-210.
12. Lundman P., Eriksson M., Schenck-Gustafsson K., Karpe F., and Tornvall P. (1997) Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation, 96, 3266-3268.
13. Lundman P., Eriksson M.J., Silveira A., Hansson L.O., Pernow J., Ericsson C.G., Hamsten A., and Tornvall P. (2003) Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1). The American Journal of Cardiology, 91, 1128-1131.
14. Lundman P., Eriksson M.J., Stuhlinger M., Cooke J.P., Hamsten A., and Tornvall P. (2001) Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. Journal of American College of Cardiology, 38, 111-116.
15. Lupattelli G., Lombardini R., Schillaci G., Ciuffetti G., Marchesi S., Siepi D., and Mannarino E. (2000) Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: Association with small, dense LDL cholesterol particles. American Heart Journal, 140, 521-526.
16. McVeigh G.E., Brennan G.M., Johnston G.D., McDermott B.J., McGrath L.T., Henry W.R., Andrews J.W., and Hayes J.R. (1993) Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 36, 33-38.
17. Playford D.A., Watts G.F., Best J.D., and Burke V. (2002) Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus. The American Journal of Cardiology, 90, 1254-1257.
18. Rizos E., Kostoula A., Elisaf M., and Mikhailidis D.P. (2002) Effect of ciprofibrate on C-reactive protein and fibrinogen levels. Angiology, 53, 273-277.
19. Sampietro T., Tuoni M., Ferdeghini M., Ciardi A., Marraccini P., Prontera C., Sassi G., Taddei M., and Bionda A. (1997) Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation, 96, 1381-1385.
20. Sardo M.A., Castaldo M., Cinquegrani M., Bonaiuto M., Maesano A., Schepis F. Zema M.C., Campo G.M., Squadrito F., and Saitta A. (2001) Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects. Atherosclerosis, 155, 143-147.
21. Schneider M.P., Delles C., Fleischmann E., Schmidt B.M., John S., and Schmieder R.E. (2203) Effect of elevated triglyceride levels on endothelium-dependent vasodilation in patients with hypercholesterolemia. The American Journal of Cardiology, 91, 482-484.
22. Shih P.T., Elices M.J., Fang Z.T., Ugarova T.P., Strahl D., Territo M.C., Frank J.S., Kovach N.L., Cabanas C., Berliner J.A., and Vora D.K. (1999) Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin. Journal of Clinical Investigation, 103, 613-625.
23. Steinberg H.O., Tarshoby M., Monestel R., Hook G., Cronin J., Johnson A., Bayazeed B., and Baron A.D. (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. Journal of Clinical Investigation, 100, 1230-1239.
24. Steinberg M.D., and Lewis A. (1997) Conner Memorail Lecture: Oxidative modification of LDL and atherogenesis. Circulation, 95, 1062-1071.
25. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes D.R. Jr., and Lerman A. (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation, 101, 948-954.
26. Van Snick J. (1990) Interleukin-6: An overview. Annual Review of Immunology, 8, 253-278.
27. Wada H., Mori Y., Kaneko T., Wakita Y., Nakase T., Minamikawa K., Ohiwa M., Tamaki S., Tanigawa M., and Kageyama S. (1993) Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia. American Journal of Hematology, 44, 112-116.
28. Wang T.D., Chen W.J., Lin J.W., Cheng C.C., Chen M.F., and Lee Y.T. (2003) Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: Relations with baseline lipid profiles. Atherosclerosis, 170, 315-323.
29. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. (1999) C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arteriosclerosis Thrombosis and Vascular Biology, 19, 972-978.